Cargando…

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome

To determine the predictive value of a raised androgen level with an elevated anti-Müllerian hormone (AMH) for the diagnosis or exclusion of polycystic ovary syndrome (PCOS), a prospective cross-sectional study of 170 women (105 with PCOS type A and 65 normal) was undertaken. AMH was combined with o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sathyapalan, Thozhukat, Al-Qaissi, Ahmed, Kilpatrick, Eric S., Dargham, Soha R., Keevil, Brian, Atkin, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830572/ https://www.ncbi.nlm.nih.gov/pubmed/29491484 http://dx.doi.org/10.1038/s41598-018-22176-1

Ejemplares similares

Salivary testosterone measurement in women with and without polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome
por: Cho, Li-Wei, et al.
Publicado: (2017)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population
por: Dargham, Soha R., et al.
Publicado: (2017)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Exploration of the correlation of serum polychlorinated biphenyl levels with luteal phase hormonal parameters and infertility in women with or without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
por: Sivanandy, Mala S., et al.
Publicado: (2023)

The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
por: Alalami, Huda, et al.
Publicado: (2018)

Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
por: Butler, Alexandra E., et al.
Publicado: (2020)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
por: Ahmed, Nada, et al.
Publicado: (2019)

The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects
por: Al-Qaissi, Ahmed, et al.
Publicado: (2019)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

The Effect of High Dose Isoflavone Supplementation on Serum Reverse T(3) in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
por: Dargham, Soha R., et al.
Publicado: (2018)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
por: Kollmann, Martina, et al.
Publicado: (2019)

A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2020)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
por: Brennan, Edwina, et al.
Publicado: (2023)

ODP141 Complement Activation and Homeostasis Works Primarily Through the Alternative Pathway in Polycystic Ovary Syndrome
por: Atkin, Stephen, et al.
Publicado: (2022)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
por: Javed, Zeeshan, et al.
Publicado: (2019)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

The Association of the Polychlorinated Biphenyl Class of Endocrine Disruptors With Polycystic Ovary Syndrome and Thyroid Dysfunction
por: Brennan, Edwina, et al.
Publicado: (2021)

The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Kim, Hye Ok
Publicado: (2013)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
por: Dawson, Alison J., et al.
Publicado: (2017)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Evaluation of relationship between serum levels of anti-müllerian hormone, androgen, and insulin resistant with retrieval oocytes in overweight patients with polycystic ovary syndrome
por: Aghadavod, Esmat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lulsln1iqbr2b4u53v01o7jkat